2018 Group Company Advanced Collective and Advanced Individual
Release time:
2020-07-22
2018 Group Company Advanced Collective, Advanced Individual
1. Advanced Collective
Advanced Enterprise ():
Daye Jianfeng Cement Co., Ltd.
Tianjin Jianfeng Natural Products Research and Development Co., Ltd.
Advanced Party Organization (2 ):
CPC Yunnan Jianfeng Cement Co., Ltd. Party Branch
CPC Jinhua Pharmaceutical Co., Ltd. Party General Branch
Advanced Civilization Workshop (Department)( 5 ):
Peak International Trade Co., Ltd. Customer Service Center
Jinhua Pharmaceutical Company Traditional Chinese Medicine Sales Department
Peak Communication Cable Co., Ltd. Cable Workshop
Yunnan Peak Cement Co., Ltd. Marketing Department
Da Peak Metallurgical Cement Co., Ltd. Manufacturing Department
Advanced Civilization Team (8 ):
Peak Health Technology Company Extracts Canned Group
Peak Communication Cable Co., Ltd. Marketing Department
Daye Peak Cement Co., Ltd. General Management Department Canteen Class
Peak Pharmacy Shijinge Pharmacy
Peak International Trade Co., Ltd. Jinhua South Station Team
Pharmaceutical Company Jinxi Factory Electrician Team
Jinhua Office of Terminal Department of Jianfeng Pharmaceutical Sales Company
Yunnan Jianfeng Cement Co., Ltd. Production and Manufacturing Department Class C
Advanced Trade Union Organization (1 ):
Daye Jianfeng Cement Co., Ltd. Trade Union Committee
2. Outstanding Individuals
Outstanding Employees (10 ):
Peak Health Technology Chen Anping
International Trade Company Chen Lihua
Pharmaceutical Company Quality Department Li Xujin
Pharmaceutical Sales Company Yu Weiyao
Daye Peak Cao Kaiqiang
Daye Peak Chen Changfa
Yunnan Peak Zhu Ruxian
Yunnan Peak Yu Dingrong
Cable Company Zhu Meixian
Group Company Office Pan Lijun
Innovation Expert (7 ):
Jinxi Pharmaceutical Factory Liu Bin
Natural Products Company Sun Huageng
Daye Peak Du Yuwen
Cable Company Hu Longgang
Yunnan Peak Li Shaowen
International Trade Company Xiang Chunlin
Jinhua Pharmaceutical Company Ying Lu
Outstanding Management Worker (3 )
Daye Peak Hu Hongwei
Yunnan Peak Fang Xuhua
Pharmaceutical Company Gong Xiliang
Excellent Salesman (6 ):
Daye Peak Li Army
Pharmacy Xinhua Pharmacy Wang Xiuling
Yunnan Peak Qiu Xianya
Cable Company Chapter Ci
Pharmaceutical Sales Company Ni Guocheng
Peak Health Technology Cheng Guo
3. Advanced Individual
Outstanding Party Worker (2 ):
Yunnan Peak Tan Guojian
Pharmaceutical Sales Company Xu Junxiong
Outstanding Communist Party Member (5 ):
Jinxi Pharmaceutical Factory Zheng Kunwu
Daye Peak Jiang Binhui
Yunnan Peak Building Xuxin
Group Company Office Fu Yiwu
International Trading Company Du Lin
Outstanding Trade Union Workers (2 ):
Daye Peak Zhu Yong
Yunnan Peak Yang Shunchang
Trade Union Activists (2 ):
Jinhua Pharmaceutical Company Fan Tufa
Yunnan Jianfeng Li Li
Advanced Worker of Safety and Environmental Protection (5 ):
Cable Company Wang Debo
Peak Health Technology Zhou Guangming
Yunnan Peak Ruan Wencai
Pharmaceutical Company Lu Xianhui
International Trading Company Fang Xuming
Rookie Staff (3 ):
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31